Our previous research has preliminarily elucidated the pharmacological effects and mechanisms of Bi-Qi capsules in acute gouty arthritis; they are able to reduce serum uric acid levels, enhance uric acid clearance rates, and ameliorate renal injury, ankle joint swelling, and synovial injury by controlling the expression of adenosine deaminase, organic anion transporter 1, and glucose transporter 9, inhibiting the NLRP3 pathway and TLR4/NLRP3 pathway, reducing the levels of inflammatory factors [17]. This evidence concerns the gene NLRP3 and gout.